KLK3 and metastatic neoplasm: If PSA progression during treatment with ADT occurs prior to the detection of metastases, patients enter an nmCRPC state (15), defined by serum testosterone <50 ng/dL and rising PSA in the absence of radiographic evidence of metastatic disease (16).